Report of Foreign Issuer (6-k)

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of January, 2019

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _______ No ___X____

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In December 2018:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. ⁽¹⁾

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.	CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury

Initial Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾	Quantity

Shares	Common	1,882,713

Transac tions in the month
Securities / Derivatives	Securities Characteristics ⁽²⁾	Intermediary	Operation	Day	Quantity	Price	Volume ⁽³⁾
Shares	Common	Direct with the Company	Conversion into ADRs	19	82,675	0.00	0.00
			Total Conversion into ADRs		82,675		0.00
Shares	Common	Direct with the Company	Exerc Options	04	45,175	R$ 9.35960	R$ 422,819.93
Shares	Common	Direct with the Company	Exerc Options	04	25,385	R$ 11.97200	R$ 303,909.22
Shares	Common	Direct with the Company	Exerc Options	19	701,175	R$ 0.43648	R$ 306,048.86
			Total Sell		771,735		R$ 1,032,778.01

Final Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾	Quantit y

Shares	Common	1,028,303

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price .

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In December 2018:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. ⁽¹⁾

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.	CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury

Initial Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾	Quantity

ADR ^(*)	Common	0

Transac tions in the month
Securities / Derivatives	Securities Characteristics ⁽²⁾	Intermediary	Operation	Day	Quantity	Price	Volume ⁽³⁾
ADR ^(*)	Common	Direct with the Company	Conversion into ADRs	19	82,675	0.00	0.00
			Total Conversion into ADRs		82,675		0.00

ADR ^(*)	Common	Direct with the Company	Exerc Options	19	82,675	USD 7.26	USD 600,220.50
			Total Sell		82,675		USD 600,220.50

Final Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾	Quantity

ADR ^(*)	Common	0

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price .

(*) Each ADR is equivalent to 1 (one) share.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: January 10, 2019